quinazolines has been researched along with casein kinase ii in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liang, NC; Liu, XG | 1 |
| Fabbro, D; Furet, P; Portmann, R; Schoepfer, J; Vangrevelinghe, E; Zimmermann, K | 1 |
| Bain, J; Battistutta, R; de Moliner, E; Elliott, M; Fabbro, D; Furet, P; Meggio, F; Pagano, MA; Pinna, LA; Ruzzene, M; Sarno, S; Schoepfer, J; Zanotti, G | 1 |
| Di Maira, G; Frascella, P; Lucchini, V; Mazzorana, M; Meggio, F; Pagano, MA; Pinna, LA; Ruzzene, M; Sarno, S; Zambon, A | 1 |
| Berger, SH; Johnson, SR; Lebioda, L; Luo, B; Repalli, J; Yousef, AM | 1 |
| Anderes, K; Bliesath, J; Bunag, D; Drygin, D; Ho, C; Huser, N; Lim, JK; O'Brien, SE; Omori, M; Proffitt, C; Rice, WG; Ryckman, DM; Siddiqui-Jain, A; Streiner, N | 1 |
| Choi, CM; Choi, YJ; Chun, YJ; Kim, CH; Kim, SY; Kim, WS; Lee, JC; Rho, JK; So, KS; Song, JS | 1 |
| Dong, X; Li, K; Li, Q; Li, Z; Liu, L; Meng, R; Wu, G; Zhang, S; Zhou, F; Zhou, Y | 1 |
| Dong, XR; Li, K; Li, QW; Li, ZY; Liu, L; Ma, H; Meng, R; Wu, G; Zhang, S; Zhou, FZ; Zhou, Y | 1 |
| Benveniste, EN; Dees, KJ; Gibson, SA; Hjelmeland, AB; McFarland, BC; Meares, GP; Nozell, SE; Rajbhandari, R; Rowse, AL | 1 |
| Li, K; Li, Q; Li, Z; Liu, L; Meng, R; Wu, G; Zhang, S; Zhou, F; Zhou, Y | 1 |
11 other study(ies) available for quinazolines and casein kinase ii
| Article | Year |
|---|---|
Inhibitory effect and its kinetic analysis of tyrphostin AG1478 on recombinant human protein kinase CK2 holoenzyme.
Topics: Casein Kinase II; Caseins; DNA-Binding Proteins; Enzyme Inhibitors; Guanosine Triphosphate; Holoenzymes; Humans; Kinetics; Protein Serine-Threonine Kinases; Quinazolines; Recombinant Proteins; Tyrphostins | 2002 |
Discovery of a potent and selective protein kinase CK2 inhibitor by high-throughput docking.
Topics: Acetates; Amino Acid Sequence; Binding Sites; Casein Kinase II; Enzyme Inhibitors; Humans; Models, Molecular; Molecular Sequence Data; Phosphorylation; Protein Binding; Protein Serine-Threonine Kinases; Quinazolines; Sequence Homology, Amino Acid; Structure-Activity Relationship; Zea mays | 2003 |
Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-a)quinazolin-7-yl]acetic acid (IQA).
Topics: Acetates; Animals; Casein Kinase II; Cell Line; Crystallography, X-Ray; Enzyme Inhibitors; Humans; Jurkat Cells; Molecular Structure; Plant Proteins; Protein Serine-Threonine Kinases; Protein Structure, Quaternary; Quinazolines; Rats; Zea mays | 2003 |
Development and exploitation of CK2 inhibitors.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Apoptosis; Benzimidazoles; Binding Sites; Casein Kinase II; Cell Line; Cell Membrane Permeability; Coumarins; Holoenzymes; Humans; Ligands; Mutation; Protein Kinase Inhibitors; Quinazolines; Structure-Activity Relationship; Triazoles | 2005 |
Human thymidylate synthase with loop 181-197 stabilized in an inactive conformation: ligand interactions, phosphorylation, and inhibition profiles.
Topics: Amino Acid Motifs; Casein Kinase II; Circular Dichroism; Deoxyuracil Nucleotides; Diphosphonates; Humans; Ligands; Mutation; Phosphorylation; Protein Binding; Protein Structure, Secondary; Quinazolines; Structure-Activity Relationship; Thiophenes; Thymidylate Synthase | 2011 |
Combined inhibition of EGFR and CK2 augments the attenuation of PI3K-Akt-mTOR signaling and the killing of cancer cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Casein Kinase II; Cell Line, Tumor; Cell Proliferation; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Mice; Naphthyridines; Neoplasms; Phenazines; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Quinazolines; Signal Transduction; TOR Serine-Threonine Kinases | 2012 |
Autophagosome-mediated EGFR down-regulation induced by the CK2 inhibitor enhances the efficacy of EGFR-TKI on EGFR-mutant lung cancer cells with resistance by T790M.
Topics: Apoptosis; Autophagy; Casein Kinase II; Cell Line, Tumor; Drug Resistance, Neoplasm; ErbB Receptors; Erlotinib Hydrochloride; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mutation; Naphthyridines; Phagosomes; Phenazines; Protein Kinase Inhibitors; Quinazolines | 2014 |
Quinalizarin, a specific CK2 inhibitor, reduces cell viability and suppresses migration and accelerates apoptosis in different human lung cancer cell lines.
Topics: Adenocarcinoma; Apoptosis; Carcinoma, Large Cell; Casein Kinase II; Cell Movement; Cell Proliferation; Flow Cytometry; Humans; Lung Neoplasms; Quinazolines; Small Cell Lung Carcinoma; Tumor Cells, Cultured | 2015 |
[The CK2 inhibitor quninalizarin enhances the anti-proliferative effect of icotinib on EGFR-TKIs-resistant cell lines and its underlying mechanisms].
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Analysis of Variance; Anthraquinones; Apoptosis; Casein Kinase II; Cell Line, Tumor; Cell Proliferation; Cell Survival; Crown Ethers; Down-Regulation; Drug Combinations; Drug Resistance, Neoplasm; Drug Synergism; ErbB Receptors; Humans; Lung Neoplasms; Phosphorylation; Protein-Tyrosine Kinases; Quinazolines; Signal Transduction | 2016 |
Protein kinase CK2 is important for the function of glioblastoma brain tumor initiating cells.
Topics: AC133 Antigen; Animals; Brain Neoplasms; Casein Kinase II; Cell Line, Tumor; Cell Proliferation; Embryo, Mammalian; Enzyme Inhibitors; Female; Gefitinib; Glioblastoma; Humans; Mice; Mice, Inbred C57BL; Mice, Nude; Naphthyridines; Neoplastic Stem Cells; Phenazines; Pregnancy; Quinazolines; RNA, Small Interfering; Signal Transduction; Xenograft Model Antitumor Assays | 2017 |
Quinalizarin, a specific CK2 inhibitor, can reduce icotinib resistance in human lung adenocarcinoma cell lines.
Topics: Adenocarcinoma of Lung; Anthraquinones; Antineoplastic Agents; Apoptosis; Casein Kinase II; Cell Line, Tumor; Cell Proliferation; Crown Ethers; Drug Resistance, Neoplasm; Humans; Lung Neoplasms; Protein Kinase Inhibitors; Quinazolines | 2019 |